«But a great deal of work lies ahead to see if this compound has the potential to serve as a less toxic treatment for fungal
infections in human patients.
A clinical trial to evaluate whether the ointment can treat antibiotic resistant
infections in human patients is scheduled for 2018.
Not exact matches
Nonetheless, if the results translate from mice to
humans, they could help inform strategies to prevent secondary
infection in patients experiencing sepsis.
But the new test found another seven, including a respiratory virus called
human adenovirus B type 3A, which usually is harmless but can cause severe
infections in some
patients.
«The
human genes and pathways that Tat manipulates correlate well with symptoms observed
in these
patients, such as immune system hyperactivation, then weakening, and accelerated aging,» Dr. D'Orso said, describing the situation
in which HIV
infection leads to AIDS.
Researchers have used radioimmunotherapy (RIT) to destroy remaining
human immunodeficiency virus (HIV)- infected cells
in the blood samples of
patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV
infection.
Clinicians treating
patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS - CoV), a virus first detected
in humans in 2012 that has since caused 614 laboratory - confirmed
infections, including 181 that were fatal, according to the World Health Organization.
The researchers are now testing this approach
in mice, and they envision that eventually the technology could be adapted to deliver the CRISPR components to treat
infections or remove other unwanted bacteria
in human patients.
«The use of
human cellular membranes as a decoy has the potential to block a large family of related microbial toxins and reduce the severity of invasive bacterial
infections in vulnerable
patients,» said Escajadillo.
Though the findings were made
in mice, not
humans, the researchers say the crucial role of calcium may help explain another mystery: Why some hospital
patients and nursing home residents have a much higher risk of contracting C. diff
infections and the resulting diarrhea that carries its spores out of the body.
That finding indicates that very low numbers of the cells
in the body could be enough to protect
human patients from maladies ranging from
infections to cancer.
Tests
in mice and nonhuman primates had shown TGN1412 to be safe, but when it was injected into
humans —
in a dose less than 1/500 of what was given to monkeys — it caused a massive release of
infection - fighting T cells that overstimulated the
patients» immune systems, resulting
in multiple organ failure.
These images provide the first 3D ultrastructural details on HIV
infection and virus production
in a setting that closely resembles the gut of
human patients.
The researchers next showed that the Smurf1 gene controls M. tuberculosis growth
in human macrophages and that the Smurf1 protein was found
in association with bacteria
in the lungs of
patients with tuberculosis
infections.
Together, these communication and defense capabilities allow P. aeruginosa to form tightly packed layers called biofilms, which can cause respiratory tract
infections in humans and are particularly dangerous to cystic fibrosis
patients.
OpenBiome was founded to expand safe access to fecal transplantation for
patients with recurrent C. difficile
infection and to catalyze research on the role of the microbiome
in human health.
About OpenBiome OpenBiome is the first public stool bank, founded to expand safe access to fecal transplantation for
patients with recurrent C. difficile
infection and to catalyze research on the microbiome's role
in human health.
In collaboration with Dr. Josh Thaden and Vance Fowler, Duke University Medical Center, we are exploring relationships between bacterial genetic variation, emergence of AMR, and patient outcome in Enterobacter and Escherichia coli Bloodstream Infections (BSI) by leveraging the Duke University Bloodstream Infection Biorepository (BSIB), which contains robust clinical data, bacterial bloodstream isolates, and corresponding human sera and DNA from over 2000 patients with BSI caused by Gram - negative bacteria at Duke Hospital since 200
In collaboration with Dr. Josh Thaden and Vance Fowler, Duke University Medical Center, we are exploring relationships between bacterial genetic variation, emergence of AMR, and
patient outcome
in Enterobacter and Escherichia coli Bloodstream Infections (BSI) by leveraging the Duke University Bloodstream Infection Biorepository (BSIB), which contains robust clinical data, bacterial bloodstream isolates, and corresponding human sera and DNA from over 2000 patients with BSI caused by Gram - negative bacteria at Duke Hospital since 200
in Enterobacter and Escherichia coli Bloodstream
Infections (BSI) by leveraging the Duke University Bloodstream
Infection Biorepository (BSIB), which contains robust clinical data, bacterial bloodstream isolates, and corresponding
human sera and DNA from over 2000
patients with BSI caused by Gram - negative bacteria at Duke Hospital since 2002.
A Phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160
in patients with early
human immunodeficiency virus
infection.
The
infection tests were done
in human cells, including cells derived from SMA
patients.
•
Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem cell transplant within 100 days before first dose of study drug • Known history of
human immunodeficiency virus (HIV)
infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct
in primary site or histology from the cancer evaluated
in this study • Serious, uncontrolled
infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
Pilar received her PhD
in 2017 at the Complutense University of Madrid, where she studied immune cell dysfunction and hyperactivation
in HIV / HCV coinfected
patients, as well as the
in vitro and
in vivo activity of nanoparticles against HIV - 1 and HSV - 2
infections to prevent their transmission
in humans as a topical microbicide.
Two differences
in the comparison of experimental monkeys with
human patients include the use of multiple ticks for
infection and a lab - propagated strain of B. burgdorferi.
He and his colleagues were the first to demonstrate that
human antigen - specific T cell clones could be isolated and expanded
in vitro and then re-infused into
patients to prevent or treat viral
infections and to mediate therapeutic responses
in patients with cancer.
The team of researchers harvested hematopoietic stem cells from three macaques prior to SHIV
infection of all six animals
in the study, treated the animals with anti-retroviral therapy (ART) to reduce viral load and mimic the situation
in human HIV - infected
patients who are treated with ART, and then exposed the three monkeys from which they had collected hematopoietic stem cells to a high dose of radiation.
Infections with
human pathogenic fungi have been continuously increasing during the last years and these fungal pathogens have become a major threat for individuals,
in particular for
patients with a compromised immune system.
Median = 5 years, [E] ight were hospitalized... The outbreak strain was isolated from a pet turtle
in a
patient's home... This outbreak demonstrates that turtles remain a source for
human Salmonella
infections, especially for young children.
Recent advances
in diagnostic techniques have facilitated documentation of chronic bloodstream
infections with Bartonella spp.
in healthy and sick animals, and
in immunocompetent and immunocompromised
human patients with cardiovascular, neurologic, and rheumatologic symptoms.
AHP ® is unique
in its ability to help keep
humans and animals free from
infection, while being safer for users,
patients and assets.
Dworkin, M.S., et al Bordetella bronchiseptica
Infection in Human Immunodeficiency Virus — Infected
Patients Clinical Infectious Diseases, 1999
Petrie, K.J., Pennebaker, J.W. et al. (2004) Effect of Written Emotional Expression on Immune Function
in Patients With
Human Immunodeficiency Virus
Infection: A Randomized Trial.
It also addresses social isolation, a factor that has been linked to increased mortality and morbidity
in some studies of
patients with CAD.25 Furthermore, IPT was found to be superior to CBT
in treating depression
in patients with
human immunodeficiency virus
infection, 26 a group also dealing with comorbid physical and emotional problems.